Back to UBS Group AG UBS Group AG

MENSMENS
4 quarters

Position history for UBS Group AGUBS Group AG's holdings in JYONG BIOTECH LTD

Yes. Ubs holds 4,046 shares of MENS (Jyong Biotech), worth $8,376, as of its Q2 2026 13F filing. It reduced the position by 33,317 shares (-89.2%) from Q1 2026. Ubs has held MENS since Q3 2025, across 4 quarterly 13F filings.

Current Value

$8,376

Current Shares

4,046

Total Value Change

-$12,771

Total Shares Change

+3,509

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
4,046
-89.2%
$8,3760.0%$2.07
0
2026-Q1
Decreased
37,363
-74.3%
$80,3310.0%$2.15
0
2025-Q4
Increased
145,648
+270x
$575,3100.0%$3.95
39
2025-Q3
New
537
-
$21,1470.0%$39.38
29

Other major holders of MENS: GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., HRT FINANCIAL LP, CITADEL ADVISORS LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used